Page last updated: 2024-09-03

imatinib mesylate and MODS

imatinib mesylate has been researched along with MODS in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chelysheva, EY; Galstyan, GM; Khuazheva, NK; Kovrigina, AM; Nemchenko, IS; Savchenko, VG; Turkina, AG	1

Other Studies

1 other study(ies) available for imatinib mesylate and MODS

Article	Year
[FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy]. Terapevticheskii arkhiv, 2015, Volume: 87, Issue:12 Topics: Adult; Dasatinib; Eosinophilia; Female; Humans; Imatinib Mesylate; mRNA Cleavage and Polyadenylation Factors; Multiple Organ Failure; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Receptor, Platelet-Derived Growth Factor alpha	2015

Article

Year

[FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy].

Terapevticheskii arkhiv, 2015, Volume: 87, Issue:12

Topics: Adult; Dasatinib; Eosinophilia; Female; Humans; Imatinib Mesylate; mRNA Cleavage and Polyadenylation Factors; Multiple Organ Failure; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Receptor, Platelet-Derived Growth Factor alpha

2015